Submission date
30/09/2004
Registration date
30/09/2004
Last edited
05/04/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Not Applicable
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Dr B Taylor

ORCID ID

Contact details

X-Ray Diagnostic
Christie Hospital NHS Trust
Wimslow Road
Withington
Manchester
M20 4BX
United Kingdom

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

N0063139427

Study information

Scientific title

Acronym

Study hypothesis

To determine whether intravenous hyoscine butylbromide (Buscopan®) results in a significant improvement in magnetic resonance (MR) image quality and improves diagnostic accuracy, thereby benefitting patients.

Ethics approval(s)

Not provided at time of registration

Study design

A cohort observation, randomised single-blinded trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Hospital

Study type

Screening

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Magnetic resonance imaging (MRI)

Intervention

Before pelvic magnetic resonance imaging patient will received either intravenous hyoscine butylbromide or a placebo.

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Not Specified

Drug/device/biological/vaccine name(s)

Hyoscine butylbromide (Buscopan®)

Primary outcome measure

Overall image quality and visualisation of individual pelvic structures and visualisation of tumours on MR images, both with and without Buscopan®.

Secondary outcome measures

Not provided at time of registration

Overall study start date

20/01/2004

Overall study end date

31/12/2008

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

Patients undergoing pelvic magnetic resonance imaging.

Participant type(s)

Patient

Age group

Not Specified

Sex

Not Specified

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

20/01/2004

Recruitment end date

31/12/2008

Locations

Countries of recruitment

England, United Kingdom

Study participating centre

X-Ray Diagnostic
Manchester
M20 4BX
United Kingdom

Sponsor information

Organisation

Department of Health

Sponsor details

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Sponsor type

Government

Website

http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Funder name

Christie Hospital NHS Trust (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/11/2007 Yes No

Additional files

Editorial Notes